• Aethlon Medical (San Diego) reported that it has expanded the applications of its Hemopurifier platform technology to address voids in the infectious disease diagnostic market. The Aethlon Hemopurifier is a first-in-class artificial adjunct to the immune system able to provide real-time capture of infectious viruses and immunosuppressive particles from the entire circulatory system. The device is a broad-spectrum treatment candidate for acute and chronic virus infections.

• EaglePicher Medical Power (Joplin, Missouri), a supplier of batteries for implantable medical devices, reported the availability of two new, mini, Lithium-ion batteries developed to meet a growing demand for smaller, longer lasting, implantable medical devices. The two D-shaped Li-ion batteries, which each weigh under 2.3 and 3 grams (less than a small watch battery), provide capacity of more than 50mAh and 60mAh respectively. They join the EaglePicher Contego modular battery line, which is now compromised of five cells ranging in size from 0.5mAh to 350mAh.

• K2M (Leesburg, Virginia), a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, reported it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Cayman Buttress Plate System and Cayman Thoracolumbar Plate System, which have been designed to address the trauma and tumor market in the thoracolumbar, lumbar, and sacral areas of the spine.

Meridian Bioscience(Cincinnati) has received FDA clearance for a new test for Campylobacter. Launched as Premier Campy, the EIA test provides for optimized detection of Campylobacter infection, the most commonly diagnosed bacteria for food borne illness in the U.S. the company says there is a "significant need" for the Campy test because it provides a solution to several concerns associated with culture testing, currently the most commonly practiced lab technique for detecting the campylobacter bacteria.

• Mikai (Genova, Italy), a privately held medical device company, reported the market launch of its patented Falena Interspinous Decompression Device. Falena, a small titanium and PEEK implant inserted during minimally invasive back surgery, treats lumbar spinal stenosis (LSS) providing patient pain relief.

• NextDocs (Philadelphia) reported a major upgrade to the company's Microsoft Office SharePoint Server-based software suite for life sciences companies. Version 3.5 of the NextDocs Regulatory Document Management System includes an entirely new module for managing clinical documents as well as new features that enhance users' ability to easily manage regulated content. the operative environment.

No Comments